IRIS
SAVINO, Rocco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.647
AS - Asia 1.798
EU - Europa 793
SA - Sud America 469
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 5.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.542
SG - Singapore 844
CN - Cina 459
BR - Brasile 374
IT - Italia 354
VN - Vietnam 208
IN - India 177
SE - Svezia 118
DE - Germania 101
CA - Canada 84
GB - Regno Unito 83
AR - Argentina 43
FI - Finlandia 35
HK - Hong Kong 22
ID - Indonesia 18
EC - Ecuador 16
ZA - Sudafrica 16
PL - Polonia 15
ES - Italia 14
MX - Messico 14
BD - Bangladesh 12
JP - Giappone 11
UA - Ucraina 11
CZ - Repubblica Ceca 10
TR - Turchia 10
CO - Colombia 8
RU - Federazione Russa 8
CL - Cile 7
MA - Marocco 7
PY - Paraguay 7
RO - Romania 7
AT - Austria 6
EU - Europa 6
FR - Francia 6
IQ - Iraq 6
PE - Perù 6
AU - Australia 5
KE - Kenya 5
UY - Uruguay 5
UZ - Uzbekistan 5
EG - Egitto 4
IR - Iran 4
NL - Olanda 4
AE - Emirati Arabi Uniti 3
SA - Arabia Saudita 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
PK - Pakistan 2
SI - Slovenia 2
SV - El Salvador 2
TN - Tunisia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
JO - Giordania 1
KI - Kiribati 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.757
Salva come PNG Salva come JPEG
Città #
Dallas 519
Chandler 357
Singapore 250
Santa Clara 155
Bengaluru 143
Hefei 142
Milan 134
Princeton 134
Lawrence 130
Ashburn 107
Wilmington 79
Catanzaro 70
Ho Chi Minh City 70
Ottawa 67
Beijing 64
Munich 63
London 54
Chicago 52
Boardman 50
Hanoi 43
Des Moines 41
São Paulo 34
Turku 32
Shanghai 30
Troina 27
Guangzhou 23
New York 22
Hong Kong 21
Los Angeles 18
The Dalles 18
Columbus 17
Seattle 16
Norwalk 15
Rio de Janeiro 15
Warsaw 15
Council Bluffs 14
Naples 13
Florence 12
San Francisco 12
Wuhan 12
Curitiba 11
Falls Church 11
Pune 11
Boston 10
Brooklyn 10
Tokyo 10
Da Nang 9
Haiphong 9
Olomouc 9
Redmond 9
Cicciano 8
Rome 8
Salvador 8
Atlanta 7
Belo Horizonte 7
Biên Hòa 7
Bắc Ninh 7
Campinas 7
Hải Dương 7
Johannesburg 7
Quito 7
Shenzhen 7
Ann Arbor 6
Brasília 6
Buenos Aires 6
Bắc Giang 6
Guayaquil 6
Hanover 6
Phoenix 6
Porto Alegre 6
Cape Town 5
Charlotte 5
Guarulhos 5
Jiaxing 5
Nairobi 5
New Delhi 5
Parenti 5
Redwood City 5
Tashkent 5
Thái Bình 5
Washington 5
Chennai 4
Denver 4
Girona 4
Horia 4
Jakarta 4
Maceió 4
Manchester 4
Montevideo 4
Mountain View 4
Sorocaba 4
Stockholm 4
Toronto 4
West Jordan 4
Amsterdam 3
Ankara 3
Asunción 3
Buffalo 3
Cairo 3
Can Tho 3
Totale 3.449
Salva come PNG Salva come JPEG
Nome #
Untargeted metabolomics fingerprints in seminal plasma of patients with abnormal sperm morphology using high-performance liquid chromatography and mass spectrometry 181
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 81
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 80
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 77
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 75
Application of proteomics and peptidomics to COPD 69
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 68
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 68
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 66
An alternative approach for the identification of potential prostate cancer biomarkers 65
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 65
Mesopore-assisted Profiling of Human Synovial Fluid 63
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 63
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 62
Associazione di antagonisti di IL-6 e farmaci anti-proliferativi (depositato il 10.3.2005 n. RM2005A000103) 62
Asthma and COPD proteomics: Current approaches and future directions 61
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 61
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 58
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 57
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 57
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 57
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 57
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 55
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 55
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 55
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 55
MALDI MS-Based Investigations Targeting SARS-CoV-2 55
Adenovirus-mediated gene transfer of a human IL-6 antagonist 54
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 54
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 53
Liquid Cristalline Phases for the Ophthalmic Administration of Drug 51
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 51
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 51
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 50
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 50
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 50
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 49
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 49
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 49
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 49
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 48
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 48
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis 48
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 48
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 47
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 47
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 47
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 47
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 47
Involvement of the Arg179 in the active site of human IL-6 47
Biologics in severe asthma 47
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 47
TLR4 triggered complex inflammation in human pancreatic islets 45
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 45
Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? 44
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 44
A ROLE FOR U3 SMALL NUCLEAR RIBONUCLEOPROTEIN IN THE NUCLEOLUS 44
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 43
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 43
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 43
Human IL-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells 42
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 42
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) 41
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 41
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 41
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 41
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 40
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 40
Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism 40
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 39
Human Herpesvirus Type 8 (HHV-8) Interleukin-6 homologue is functionally active on human myeloma cells 39
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation 39
C3f is a potential tool for the staging of osteoarthritis 39
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 39
The molecular design of human IL-6 receptor antagonists 38
PRERIBOSOMAL RNA PROCESSING IN XENOPUS-OOCYTES DOES NOT INCLUDE CLEAVAGE WITHIN THE EXTERNAL TRANSCRIBED SPACER AS AN EARLY STEP 38
Effect of IL-6 variants in Multiple Myeloma:growth inhibition and induction of apoptosis in primary cells 38
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 38
In Mesopore Protein Digestion: A New Forthcoming Strategy in Proteomics 38
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 38
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 37
Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a Helper-Dependent Adenoviral vector 37
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 37
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 36
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus 36
test di Valutazione di efficacia dei chemioterapici effettuato su tre distinte e complementari popolazioni cellulari derivate dalla massa tumorale solida 35
EXTRA-RIBOSOMAL SPACER SEQUENCES IN TRITURUS 35
Generation of IL-6 antagonists by substituting residues in helix A 35
Cytokine Inhibitors 35
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 35
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 35
Monovalent phage display of human Interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in hIL-6 D-helix 35
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells 35
REGULATION OF U3 SNRNA GENE-EXPRESSION 34
Identification of residues critical for biological activity and receptor binding of human Interleukin-6 34
Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation 34
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model of human multiple myeloma 34
Designing new agonists/antagonists of growth factor receptors- The rational design of a super-antagonist of the IL-6 receptor 33
Treatment with an adenoviral vector expressing the IL-6 receptor superantagonist sant7 compared with the treatment with the recombinant sant7 protein in MM cell lines 32
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 31
Totale 4.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 7 2 3 5 136 8 0 6
2021/2022362 2 0 10 90 37 10 17 78 30 32 55 1
2022/20231.070 267 45 50 76 117 132 5 60 169 44 83 22
2023/2024420 63 59 54 22 26 100 4 24 5 7 11 45
2024/20251.527 216 140 77 87 122 167 5 29 183 125 143 233
2025/20262.186 172 365 717 604 328 0 0 0 0 0 0 0
Totale 5.858